A: The design of the NIBP parameter of a patient monitor is required to be proven to be safe and effective for use in the diagnosis, and treatment of disease states and underlying chronic conditions, and in the prescribing of medications and other therapies. This testing is governed by national and international standards including AAMI/ANSI SP10 and IEC 80601-1-2-30 for minimum performance and safety. The performance of NIBP monitors are required to be evaluated or tested during scheduled maintenance by the manufacturer.